http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106074488-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-27 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 |
| filingDate | 2016-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106074488-B |
| titleOfInvention | Benzene methoxycarbonyl group-Pidolidone is in the purposes for preparing BLyS antagonists |
| abstract | The invention discloses benzene methoxycarbonyl group L glutamic acid in the purposes for preparing BLyS antagonists, competitive ELISA the experimental results showed that：Benzene methoxycarbonyl group L glutamic acid can inhibit the combination of BLyS and TACI Fc.Inhibiting effect and the concentration of benzene methoxycarbonyl group L glutamic acid are proportionate.Benzene methoxycarbonyl group L glutamic acid can inhibit the combination of BLyS and BCMA Fc；Inhibiting effect and the concentration of benzene methoxycarbonyl group L glutamic acid are proportionate.Benzene methoxycarbonyl group L glutamic acid can be used as potential BLyS small molecular antagonists. |
| priorityDate | 2016-06-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 146.